CLINICAL_TRIALS
trial_result
· 2017-06-16
Clinical Trial Update: Safety and Tolerability of Odanacatib (0822-059) [Phase 1]
Summary
Phase 1 trial report on the safety and tolerability of odanacatib in osteoporosis published after completion of the study.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Osteoporosis | Phase 1 | Status: COMPLETED | Results posted: 2017-06-16